secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0001213900-25-032732
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics files ATM prospectus supplement for up to 2.17M shares; $7.7M already sold
--------------------------------------------------------------------------------

- Filed prospectus supplement to sell up to 2,169,272 shares of common stock via ATM program with H.C. Wainwright.
- Company had sold $7,655,240 in common stock under the existing ATM agreement as of the filing date.
- Wainwright earns 3.0% commission on gross proceeds from any sales under the ATM agreement.
- Company may suspend or terminate the offering at any time; no obligation to sell shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390025032732/0001213900-25-032732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390025032732/ea0238567-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-032732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer